

浏览全部资源
扫码关注微信
1.吉林医药学院吉林省抗体工程科技协同 创新中心,吉林 吉林 132013
2.吉林医药学院基础医学院,吉林 吉林 132013
3.西安交通大学第二附属 医院生物诊疗中心,西安 710299
Received:27 December 2024,
Revised:2025-05-20,
Accepted:21 May 2025,
Published:30 June 2025
移动端阅览
尹茉莉,罗文彬,徐婧哲,等.载雷公藤甲素靶向制剂的制备及质量、靶向性、细胞毒性评价 [J].中国药房,2025,36(12):1457-1462.
YIN Moli,LUO Wenbin,XU Jingzhe,et al.Preparation and evaluation of quality, targeting and cytotoxicity of triptolide-loaded targeting nanoparticles[J].ZHONGGUO YAOFANG,2025,36(12):1457-1462.
尹茉莉,罗文彬,徐婧哲,等.载雷公藤甲素靶向制剂的制备及质量、靶向性、细胞毒性评价 [J].中国药房,2025,36(12):1457-1462. DOI: 10.6039/j.issn.1001-0408.2025.12.07.
YIN Moli,LUO Wenbin,XU Jingzhe,et al.Preparation and evaluation of quality, targeting and cytotoxicity of triptolide-loaded targeting nanoparticles[J].ZHONGGUO YAOFANG,2025,36(12):1457-1462. DOI: 10.6039/j.issn.1001-0408.2025.12.07.
目的
2
制备雷公藤甲素(TP)纳米粒子靶向制剂,并评价其质量、靶向性和细胞毒性作用。
方法
2
使用乳化挥发法,以聚乳酸-羟基乙酸共聚物/聚乙二醇/叶酸(PLGA-PEG-FA)为载体,制备载TP靶向FA受体的聚合物纳米粒子(TP@PLGA-PEG-FA),观察其形态及分布,测定其粒径、Zeta电位、多分散性指数(PDI)、载药量、包封率,评价其稳定性、血液相容性、体外释药情况、RAW264.7细胞摄取情况(以荧光染料Cy3.5定位)和体外细胞毒性。
结果
2
TP@PLGA-PEG-FA呈球形,分布均匀,粒径为(122.60±0.02)nm,Zeta电位为(-17.6±0.6)mV,PDI为0.26±0.02;TP的载药量和包封率分别为(7.78±0.05)%和(68.62±0.03)%;其在4 ℃水中放置14 d和在37 ℃、含有10%胎牛血清的DMEM培养基中放置12 h的粒径、PDI、Zeta电位均无明显变化。100、200、300、400 µg/mL TP@PLGA-PEG-FA的溶血率分别为0.77%、0.92%、1.34%、1.63%。TP@PLGA-PEG-FA在pH5.5的磷酸盐缓冲液中72 h时的累积释放量为(84.83±0.29)%,较pH7.4、6.5磷酸盐缓冲液中72 h时的累积释放量[分别为(42.37±0.35)%、(63.83±0.29)%
]
显著升高(
P
<0.05)。激活的RAW264.7细胞对Cy3.5@PLGA-PEG-FA的摄取明显多于其对Cy3.5@PLGA-PEG-FA+游离FA和Cy3.5@PLGA-PEG的摄取;当TP质量浓度≥15.63 ng/mL时,TP@PLGA-PEG-FA组激活细胞的存活率显著低于同质量浓度游离TP组(
P
<0.05)。
结论
2
所制备的TP@PLGA-PEG-FA稳定性高、血液相容性好,对炎症细胞具有主动靶向性和细胞毒性。
OBJECTIVE
2
To prepare nanoparticle-based targeting preparation loaded with triptolide (TP), and evaluate its quality, targeting ability and cytotoxic effects.
METHODS
2
Polymer nanoparticles carrying TP-targeted folic acid (FA) receptor (TP@PLGA-PEG-FA) were fabricated using poly (lactic-co-glycolic acid)/polyethylene glycol/FA (PLGA-PEG-FA) as the carrier by emulsion and volatilization technique. The morphology and distribution were observed, and their particle size, Zeta potential, polyd
ispersity index (PDI), drug loading capacity and encapsulation efficiency were measured. Their stability, blood compatibility,
in vitro
drug release, uptake by RAW264.7 cells (localization with fluorescent dye Cy3.5), and
in vitro
cytotoxicity were evaluated.
RESULTS
2
TP@PLGA-PEG-FA exhibited spherical shape and uniform distribution, with particle size of (122.60±0.02)nm, Zeta potential of (-17.6±0.6)mV, and PDI of 0.26±0.02; drug loading capacity and encapsulation efficiency of TP were measured to be (7.78±0.05)% and (68.62±0.03)%, respectively. The hemolysis rates of 100, 200, 300, 400 µg/mL TP@PLGA-PEG-FA were 0.77%, 0.92%, 1.34% and 1.63%, respectively. There were no significant changes in particle size, PDI and Zeta potential when TP@PLGA-PEG-FA were placed in 4 ℃ water for 14 days and in DMEM culture medium containing 10% fetal bovine serum at 37 ℃ for 12 h. The cumulative release rate of TP@PLGA-PEG-FA was (84.83±0.29)% in phosphate buffer at pH5.5 for 72 h, which was significantly higher than the cumulative release rates in phosphate buffer solutions at pH7.4 and 6.5 for 72 h [(42.37±0.35)% and (63.83±0.29)%, respectively
]
(
P
<0.05). Activated RAW264.7 cells took up significantly more Cy3.5@PLGA-PEG-FA than they took up Cy3.5@PLGA-PEG-FA+free FA and Cy3.5@PLGA-PEG. When the mass concentration of TP was≥15.63 ng/mL, the survival rates of activated cells in the TP@PLGA-PEG-FA groups were significantly lower than those of the same mass concentration of free TP groups (
P
<0.05).
CONCLUSIONS
2
The prepared TP@PLGA-PEG-FA has high stability, good blood compatibility, active targeting and cytotoxicity to inflammatory cells.
王明霞 , 蔡雪峰 , 林静 , 等 . 雷公藤甲素抑制类风湿性关节炎成纤维细胞样滑膜细胞的自噬与存活 [J ] . 中国热带医学 , 2021 , 21 ( 10 ): 976 - 980 .
杨丽 , 刘荣华 , 黄四碧 , 等 . 类风湿性关节炎的发病机制及治疗药物研究进展 [J ] . 中国药房 , 2021 , 32 ( 10 ): 2154 - 2159 .
STEINZ M M , EZDOGLIAN A , KHODADUST F , et al . Folate receptor beta for macrophage imaging in rheumatoid arthritis [J ] . Front Immunol , 2022 , 13 : 819163 .
黄莉 , 夏新华 , 杨磊 , 等 . 叶酸修饰的斑蝥素/黄芩苷共载脂质体处方工艺优化及其评价 [J ] . 中草药 , 2024 , 55 ( 10 ): 3267 - 3279 .
ZHANG X N , ZHANG X , WANG X P , et al . Efficient delivery of triptolide plus a miR-30-5p inhibitor through the use of near infrared laser responsive or CADY modified MSNs for efficacy in rheumatoid arthritis therapeutics [J ] . Front Bioeng Biotechnol , 2020 , 8 : 170 .
CAI B L , HU Z Y , TANG H Y , et al . Triptolide impairs genome integrity by directly blocking the enzymatic acti-vity of DNA-PKcs in human cells [J ] . Biomed Pharma-cother , 2020 , 129 : 110427 .
邓飞 , 刘勇 , 马如江 , 等 . 具有可见光响应聚合物纳米粒子的制备及性能研究 [J ] . 高分子学报 , 2023 , 54 ( 5 ): 665 - 674 .
李新健 , 游云 , 张琼玲 , 等 . 载紫杉醇的叶酸靶向PTX@FA-PLGA-NMs纳米胶束的制备及其体外抗宫颈癌HeLa细胞作用的研究 [J ] . 中国中药杂志 , 2021 , 46 ( 10 ): 2481 - 2488 .
WANG X W , GU Y X , LI Q , et al . Synergistic chemo-photothermal cancer therapy of pH-responsive polymeric nanoparticles loaded IR825 and DTX with charge-reversal property [J ] . Colloids Surf B Biointerfaces , 2022 ,209(Pt. 2 ):112164.
FARRAN B , MONTENEGRO R C , KASA P , et al . Folate-conjugated nanovehicles:strategies for cancer therapy [J ] . Mater Sci Eng C , 2020 , 107 : 110341 .
ZHAO J L , ZHAO M H , YU C H , et al . Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis [J ] . Int J Nanomedicine , 2017 , 12 : 6735 - 6746 .
REN H W , HE Y W , LIANG J M , et al . Role of liposome size,surface charge,and PEGylation on rheumatoid arthritis targeting therapy [J ] . ACS Appl Mater Interfaces , 2019 , 11 ( 22 ): 20304 - 20315 .
FERNANDES E , FERREIRA D , PEIXOTO A , et al . Glycoengineered nanoparticles enhance the delivery of 5-fluoroucil and paclitaxel to gastric cancer cells of high metastatic potential [J ] . Int J Pharm , 2019 , 570 : 118646 .
国家药典委员会 . 中华人民共和国药典:四部 [M ] . 2020年版 . 北京 : 中国医药科技出版社 , 2020 : 480 - 483 .
BASSAND C , VERIN J , LAMATSCH M , et al . How agarose gels surrounding PLGA implants limit swelling and slow down drug release [J ] . J Control Release , 2022 , 343 : 255 - 266 .
王峰 , 张超 , 郑栓 . 具有线粒体靶向性的雷公藤甲素TPP-PEG-PCL脂质体的制备及其促肝肿瘤细胞凋亡研究 [J ] . 中草药 , 2021 , 52 ( 24 ): 7473 - 7483 .
ZHANG H W , DANG Q , ZHANG Z W , et al . Development,characterization and evaluation of doxorubicin na-nostructured lipid carriers for prostate cancer [J ] . J Buon , 2017 , 22 ( 1 ): 102 - 111 .
0
Views
11
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
公网安备50010302001817